Skip to main content

Home/ Nutrition/ Group items tagged cancer_risk

Rss Feed Group items tagged

Matti Narkia

Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk - Scien... - 0 views

  •  
    Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk.
    Yin L, Raum E, Haug U, Arndt V, Brenner H.
    Cancer Epidemiol. 2009 Dec;33(6):435-45. Epub 2009 Nov 25.
    PMID: 19939760
    doi:10.1016/j.canep.2009.10.014

    CONCLUSIONS: According to available evidence from longitudinal studies, serum 25(OH)D is not associated with PC incidence.
Matti Narkia

JAMA -- Abstract: Cancer Incidence and Mortality After Treatment With Folic Acid and Vi... - 0 views

  •  
    Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B12.
    Ebbing M, Bønaa KH, Nygård O, Arnesen E, Ueland PM, Nordrehaug JE, Rasmussen K, Njølstad I, Refsum H, Nilsen DW, Tverdal A, Meyer K, Vollset SE.
    JAMA. 2009 Nov 18;302(19):2119-2126. v
    PMID: 19920236

    Conclusion Treatment with folic acid plus vitamin B12 was associated with increased cancer outcomes and all-cause mortality in patients with ischemic heart disease in Norway, where there is no folic acid fortification of foods.
Matti Narkia

Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. - Wi... - 0 views

  •  
    Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk.
    Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H.
    Aliment Pharmacol Ther. 2009 Jul 1;30(2):113-25. Epub 2009 Apr 15.
    PMID: 19392870
    DOI: 10.1111/j.1365-2036.2009.04022.x

    Conclusions Our results support suggestions that serum 25(OH)D is inversely related to CRC risk.
Matti Narkia

NEJM -- Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer - 0 views

  •  
    Calcium plus vitamin D supplementation and the risk of colorectal cancer.
    Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL, Robbins J, Rohan TE, Sarto GE, Sharma S, Stefanick ML, Van Horn L, Wallace RB, Whitlock E, Bassford T, Beresford SA, Black HR, Bonds DE, Brzyski RG, Caan B, Chlebowski RT, Cochrane B, Garland C, Gass M, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Jackson RD, Johnson KC, Judd H, Kooperberg CL, Kuller LH, LaCroix AZ, Lane DS, Langer RD, Lasser NL, Lewis CE, Limacher MC, Manson JE; Women's Health Initiative Investigators.
    N Engl J Med. 2006 Feb 16;354(7):684-96. Erratum in: N Engl J Med. 2006 Mar 9;354(10):1102.
    PMID: 16481636

    Conclusions Daily supplementation of calcium with vitamin D for seven years had no effect on the incidence of colorectal cancer among postmenopausal women. The long latency associated with the development of colorectal cancer, along with the seven-year duration of the trial, may have contributed to this null finding. Ongoing follow-up will assess the longer-term effect of this intervention.
Matti Narkia

Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk -- Raimond... - 0 views

  •  
    Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.
    Raimondi S, Johansson H, Maisonneuve P, Gandini S.
    Carcinogenesis. 2009 Jul;30(7):1170-80. Epub 2009 Apr 29. Review.
    PMID: 19403841
Matti Narkia

Vitamin D and Pancreatic Cancer Risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prev... - 0 views

  •  
    Vitamin D and pancreatic cancer risk in the alpha-tocopherol, beta-carotene cancer prevention cohort.
    Michaud DS.
    Cancer Res. 2006 Oct 15;66(20):9802-3.
Matti Narkia

Vitamin D and calcium supplementation reduces cancer risk: results of a randomized tria... - 0 views

  •  
    Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.
    Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP.
    Am J Clin Nutr. 2007 Jun;85(6):1586-91. Erratum in: Am J Clin Nutr. 2008 Mar;87(3):794.
    PMID: 17556697

    Conclusions: Improving calcium and vitamin D nutritional status substantially reduces all-cancer risk in postmenopausal women.
Matti Narkia

The beverage maté: a risk factor for cancer of the head and neck. - Head Neck... - 0 views

  •  
    The beverage maté: a risk factor for cancer of the head and neck.
    Goldenberg D, Golz A, Joachims HZ.
    Head Neck. 2003 Jul;25(7):595-601. Review.
    PMID: 12808663
    DOI: 10.1002/hed.10288
Matti Narkia

Maté: a risk factor for oral and oropharyngeal cancer - Oral Oncol. 2002 Oct;... - 0 views

  •  
    Maté: a risk factor for oral and oropharyngeal cancer.
    Goldenberg D.
    Oral Oncol. 2002 Oct;38(7):646-9. Review.
    PMID: 12167417

Matti Narkia

Sham vs. Wham: The Health Insider: Omega 3 In the News Again - Lower Advanced Prostate ... - 0 views

  •  
    A new (March 24th) report in Clinical Cancer Research, a journal of the American Association for Cancer Research, shows that Omega-3 fatty acids appear protective against advanced prostate cancer.

    Dr. John S. Witte, Ph.D., professor of epidemiology and biostatistics at the University of California San Francisco, says that previous research has shown protection against prostate cancer, but that this is one of the first studies to show protection against advanced prostate cancer.
Matti Narkia

Dietary Omega-3 Fatty Acids, Cyclooxygenase-2 Genetic Variation, and Aggressive Prostat... - 0 views

  •  
    Dietary Omega-3 Fatty Acids, Cyclooxygenase-2 Genetic Variation, and Aggressive Prostate Cancer Risk.
    Fradet V, Cheng I, Casey G, Witte JS.
    Clin Cancer Res. 2009 Mar 24. [Epub ahead of print]
    PMID: 19318492
    DOI: 10.1158/1078-0432.CCR-08-2503
Matti Narkia

Wine Won't Cut Breast Cancer Risk - 0 views

  •  
    March 9, 2009 -- Red or white wine with dinner? A new study suggests a woman's wine choice should be based on personal preference rather than any hope that a wine's color may affect its breast cancer-fighting ability.

    "We found no difference between red or white wine in relation to breast cancer risk. Neither appears to have any benefits," researcher Polly Newcomb, PhD, MPH, head of the Cancer Prevention Program at the Fred Hutchinson Cancer Research Center in Seattle, says in a news release.
Matti Narkia

Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer : The Lance... - 0 views

  •  
    Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer.
    Druesne-Pecollo N, Tehard B, Mallet Y, Gerber M, Norat T, Hercberg S, Latino-Martel P.
    Lancet Oncol. 2009 Feb;10(2):173-80. Review.
    PMID: 19185835
    doi:10.1016/S1470-2045(09)70019-
Matti Narkia

New Evidence Points To An Overlooked Risk Factor For Cancer: Acetaldehyde In Alcohol - 0 views

  •  
    New evidence by researchers at the Centre for Addiction and Mental Health (CAMH) and researchers in Germany shows that drinking alcohol is the greatest risk factor for acetaldehyde-related cancer. Heavy drinkers may be at increased risk due to exposure from multiple sources.
Matti Narkia

BBC NEWS | Health | Drink a day increases cancer risk - 0 views

  •  
    A glass of wine each evening is enough to increase your risk of developing cancer, women are being warned.\nConsuming just one drink a day causes an extra 7,000 cancer cases - mostly breast cancer - in UK women each year, Cancer Research UK scientists say
1 - 15 of 15
Showing 20 items per page